"L'Ospedale Regionale di Lugano ha due sedi (Civico e Italiano) ed è un ospedale pubblico polispecialistico dotato di moderne infrastrutture e di una tecnologia medica all'avanguardia."

During the past decade, Ospedale Regionale di Lugano conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 7 clinical trials were completed, i.e. on average, 15.2% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 6 clinical trials were completed. i.e. 26.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Regionale di Lugano" #1 sponsor was "Bayer" with 4 trials, followed by "Christian Candrian" with 4 trials sponsored, "Biogen" with 3 trials sponsored, "Fondazione Epatocentro Ticino" with 3 trials sponsored and "Swiss Group for Clinical Cancer Research" with 3 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Regionale di Lugano" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Ospedale Regionale di Lugano" with 2 trials as a collaborator, "University Hospital, Basel, Switzerland" with 2 trials as a collaborator, "University of Lausanne Hospitals" with 2 trials as a collaborator and "Australasian Kidney Trials Network" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Regionale di Lugano" are "Breast Cancer" (3 trials), "Multiple Sclerosis" (3 trials), "Alzheimer's Disease" (2 trials), "Heart Failure" (2 trials) and "Subarachnoid Hemorrhage" (2 trials). Many other conditions were trialed in "Ospedale Regionale di Lugano" in a lesser frequency.

Most popular intervention types in "Ospedale Regionale di Lugano" are "Drug" (21 trials), "Device" (17 trials), "Other" (10 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BAY2433334" (3 trials), "BAY2433334 matching placebo" (3 trials), ""white" test" (= the administration of SMOFlipid retrograde through the cystic duct)" (1 trials) and "Abdominal" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Regionale di Lugano" are 56 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Regionale di Lugano". undefined are not yet recruiting, 19 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Ospedale Regionale di Lugano, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Regionale di Lugano, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 17 trials that are defined as “Not Applicable".